4//SEC Filing
Kraus Carl N 4
Accession 0001214659-23-010919
CIK 0001398733other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:30 PM ET
Size
4.9 KB
Accession
0001214659-23-010919
Insider Transaction Report
Form 4
Kraus Carl N
Chief Medical Officer
Transactions
- Award
Common Stock
2023-08-09+150,000→ 150,000 total
Footnotes (1)
- [F1]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment
Documents
Issuer
Aquestive Therapeutics, Inc.
CIK 0001398733
Entity typeother
Related Parties
1- filerCIK 0001946475
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 4:30 PM ET
- Size
- 4.9 KB